Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tang, Zheng Hai ^a   Chen, Xin ^a   Wang, Zhao Yu ^a   Chai, Ke ^a   Wang, Ya Fang ^a   Xu, Xiao Huang ^a   Wang, Xiao Wen ^b   Lu, Jia Hong ^a   Wang, Yi Tao ^a   Chen, Xiu Ping ^a   Lu, Jin Jian ^a  

^a University of Macau   (Macao)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHALCONE DERIVATIVE; DDIT3 PROTEIN, HUMAN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HERBACEOUS AGENT; LACTATE DEHYDROGENASE; LICOCHALCONE A; MAP1LC3A PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

A-549 CELL LINE; ANTAGONISTS AND INHIBITORS; APOPTOSIS; AUTOPHAGY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENE KNOCKDOWN; GENETICS; GLYCYRRHIZA URALENSIS; HUMAN; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; PATHOLOGY; TUMOR CELL LINE;

A549 CELLS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AUTOPHAGY; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; CHALCONES; DRUGS, CHINESE HERBAL; GENE KNOCKDOWN TECHNIQUES; GLYCYRRHIZA URALENSIS; HUMANS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; TRANSCRIPTION FACTOR CHOP;

EID: 84969256135     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26241     Document Type: Article

References (51)

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin. 65, 5-29 (2015).
2. Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin. 65, 87-108 (2015).
3. Burdett, S., Stewart, L. A. & Rydzewska, L. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol. 1, 611-621 (2006).
4. Rosell, R. et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 13, 239-246 (2012).
5. Cai, K. et al. Gefitinib maintenance therapy in Chinese advanced-stage lung adenocarcinoma patients with EGFR mutations treated with prior chemotherapy. Neoplasma. 62, 302-307 (2014).
6. Schiller, J. H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 346, 92-98 (2002).
7. Rajeswaran, A., Trojan, A., Burnand, B. & Giannelli, M. Efficacy and side effects of cisplatin-and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer. 59, 1-11 (2008).
8. Galletti, E., Magnani, M., Renzulli, M. L. & Botta, M. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes. ChemMedChem. 2, 920-942 (2007).
9. Frederiks, C. N., Lam, S. W., Guchelaar, H. J. & Boven, E. Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review. Cancer Treat Rev. 41, 935-950 (2015).
10. Niemeijer, N. D., Alblas, G., van Hulsteijn, L. T., Dekkers, O. M. & Corssmit, E. P. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis. Clin Endocrinol. 81, 642-651 (2014).
11. Hao, W. et al. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways. Sci. Rep. 5, srep10336 (2015).
12. Furusawa, J. et al. Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-kappaB p65 phosphorylation at serine 276. Cell Signal. 21, 778-785 (2009).
13. Ming, L. et al. Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass. Sci. Rep. 4, srep07209 (2014).
14. Choi, A.-Y. et al. Licochalcone A induces apoptosis through endoplasmic reticulum stress via a phospholipase Cγ1-, Ca2+-, and reactive oxygen species-dependent pathway in HepG2 human hepatocellular carcinoma cells. Apoptosis. 19, 682-697 (2014).
15. Lee, C. S. et al. Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways. Eur J Pharmacol. 683, 54-62 (2012).
16. Tsai, J. P. et al. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Oncotarget. 30, 28851-28866 (2015).
17. Yao, K. et al. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1. Cancer Prev Res. 7, 139-149 (2014).
18. Kim, Y. H. et al. Antiangiogenic effect of licochalcone A. Biochem Pharmacol. 80, 1152-1159 (2010).
19. Kim, J. K., Shin, E. K., Park, J. H., Kim, Y. H. & Park, J. H. Antitumor and antimetastatic effects of licochalcone A in mouse models. J Mol Med. 88, 829-838 (2010).
20. Lee, C. K. et al. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice. Basic Clin Pharmacol Toxicol. 103, 48-54 (2008).
21. Xiao, X. Y. et al. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett. 302, 69-75 (2011).
22. Klionsky, D. J. & Emr, S. D. Autophagy as a regulated pathway of cellular degradation. Science. 290, 1717-1721 (2000).
23. Hurley, J. H. & Schulman, B. A. Atomistic autophagy: the structures of cellular self-digestion. Cell. 157, 300-311 (2014).
24. Tang, Z. H. et al. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1alpha-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells. Oncotarget. 6, 43911-43926 (2015).
25. Cao, B. et al. Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway. Sci. Rep. 4, srep05749 (2014).
26. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem J. 326, 1-16 (1997).
27. Mizushima, N. & Yoshimori, T. How to interpret LC3 immunoblotting. Autophagy. 3, 542-545 (2007).
28. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8, 445-544 (2012).
29. Mathew, R., Karantza-Wadsworth, V. & White, E. Role of autophagy in cancer. Nat Rev Cancer. 7, 961-967 (2007).
30. Heath-Engel, H., Chang, N. & Shore, G. The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene. 27, 6419-6433 (2008).
31. Clarke, R. et al. Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer Res. 72, 1321-1331 (2012).
32. Haspinger, E. R. et al. Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations. Crit Rev Oncol Hematol. 94, 213-227 (2015).
33. Sahu, N. K., Balbhadra, S. S., Choudhary, J. & Kohli, D. V. Exploring pharmacological significance of chalcone scaffold: a review. Curr Med Chem. 19, 209-225 (2012).
34. Yo, Y. T., Shieh, G. S., Hsu, K. F., Wu, C. L. & Shiau, A. L. Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway. J Agric Food Chem. 57, 8266-8273 (2009).
35. Tang, Z. H. et al. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells. J Agric Food Chem. 62, 11910-11916 (2014).
36. Zhou, J. et al. A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission. Autophagy. 11, 1259-1279 (2015).
37. Xie, S. B., He, X. X. & Yao, S. K. Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells. Int J Oncol. 47, 517-526 (2015).
38. Wang, Z. et al. Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. Carcinogenesis. 34, 128-138 (2013).
39. Yang, Z. J., Chee, C. E., Huang, S. & Sinicrope, F. A. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 10, 1533-1541 (2011).
40. Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer cell. 10, 51-64 (2006).
41. Turcotte, S. et al. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell. 14, 90-102 (2008).
42. Yoon, M. J. et al. Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin. Cell Death Dis. 5, e1112 (2014).
43. Hou, W. et al. Autophagic degradation of active caspase-8. Autophagy. 6, 891-900 (2010).
44. Gump, J. M. et al. Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1. Nat Cell Biol. 16, 47-54 (2014).
45. Oyadomari, S. & Mori, M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11, 381-389 (2004).
46. Marciniak, S. J. et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18, 3066-3077 (2004).
47. B'Chir, W. et al. Dual role for CHOP in the crosstalk between autophagy and apoptosis to determine cell fate in response to amino acid deprivation. Cell Signal. 26, 1385-1391 (2014).
48. B'Chir, W. et al. The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 41, 7683-7699 (2013).
49. Shen, S., Zhang, Y., Wang, Z., Zhang, R. & Gong, X. Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress. Int J Biol Sci. 10, 212-224 (2014).
50. Liu, K. et al. CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2. Cell Death Dis. 5, e1323 (2014).
51. Lee, I. H. et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci. USA. 105, 3374-3379 (2008).